Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20210614005282/en/Enterprise-Therapeutics-doses-first-subjects-in-Phase-I-trial-for-novel-cystic-fibrosis-therapy-ETD001
https://www.biospace.com/article/releases/forbion-portfolio-company-enterprise-therapeutics-first-in-class-tmem16a-potentiator-program-for-treatment-of-cystic-fibrosis-and-other-respiratory-diseases-acquired-by-roche/?s=79
https://www.businesswire.com/news/home/20200817005196/en/Enterprise-Therapeutics-Doses-Subjects-Phase-1-Trial